Jill Carroll, Director, 10% Owner at Pandion Therapeutics, Inc. (PAND), bought 1,899,835 shares at $18.00 ($6.5M) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,538,724 | $0 | 0.0% |
| 2 | $18.00 | 361,111 | $6.5M | 100.0% |
| Total | $3.42 avg | 1,899,835 | $6.5M | 100% |
| Filing → |
| ACLX | SELL | 2023-12-18 | $49.5M | — | Filing → |
| ACLX | SELL | 2023-06-02 | $15.3M | — | Filing → |
| ACLX | SELL | 2023-05-15 | $29.0M | — | Filing → |